NCT01854840View on ClinicalTrials.gov

Betamethasone and Severity of Hyaline Membrane Disease

CompletedOBSERVATIONAL
Enrollment

127

Participants

Timeline

Start Date

January 12, 2012

Primary Completion Date

June 30, 2017

Study Completion Date

December 31, 2018

Conditions
Pregnant Women Receive Celesten
Trial Locations (1)

75015

Necker Hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01854840 - Betamethasone and Severity of Hyaline Membrane Disease | Biotech Hunter | Biotech Hunter